TWAPF (TOWA Pharmaceutical Co) Moat Score: 3/10 (As of Jun. 30, 2026)


TWAPF TOWA Pharmaceutical Co Ltd TWAPF
86 GF Score
Price $16.83
GF Value $15.06
! 5 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Moat Score?

TOWA Pharmaceutical Co TWAPF -30.88% 86 Moat Score is 3 as of Jun. 30, 2026. GuruFocus rates TWAPF with a GF Score™ of 86/100 and a GF Value™ of $15.06. The stock has 5 warning signs investors should review. Among 1,030 Drug Manufacturers companies, TOWA Pharmaceutical Co ranks better than 86.12% on this metric.

TOWA Pharmaceutical Co has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

TOWA Pharmaceutical Co has No Moat: TOWA Pharmaceutical has limited competitive advantages, with no significant market leadership or brand strength. The company faces intense competition and lacks durable cost advantages or significant regulatory barriers.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes TOWA Pharmaceutical Co might have No Moat - Very weak/transient advantages.

TOWA Pharmaceutical Co  (OTCPK:TWAPF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

TOWA Pharmaceutical Co Moat Score Related Terms

TWAPF vs ZTS, UTHR: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TOWA Pharmaceutical Co Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Moat Score distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Moat Score falls into.


TWAPF
86GF Score
TOWA Pharmaceutical Co Ltd TWAPF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
TOWA Pharmaceutical Co (TWAPF) has a Moat Score of 3 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, TOWA Pharmaceutical Co ranks #143 out of 1030 companies in the Drug Manufacturers industry, placing it in the top 13.9%.
Is TOWA Pharmaceutical Co's Moat Score too high?
TOWA Pharmaceutical Co's current Moat Score is 3. Based on the distribution chart, TOWA Pharmaceutical Co ranks #143 out of 1030 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, TOWA Pharmaceutical Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Moat Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, TOWA Pharmaceutical Co ranks #143 out of 1030 companies for Moat Score. This places TOWA Pharmaceutical Co in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. TOWA Pharmaceutical Co's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
TOWA Pharmaceutical Co (TWAPF) has a current Moat Score of 3. The stock's GF Value™ is $15.06, compared to a current price of $16.83 — trading 11.8% above its estimated fair value. The current Moat Score is 3. TOWA Pharmaceutical Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TWAPF), the current Moat Score is 3 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (TWAPF) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of $16.83 is trading 11.8% above its estimated GF Value™ of $15.06.

Key valuation signals for TWAPF:

  • Moat Score: 3
  • GF Value™: $15.06 vs. price of $16.83 (11.8% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the TWAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan6QC:Germany
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
86GF Score

Get the complete analysis for TWAPF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.83
Price
$15.06
GF Value